Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer.

MLA

Li CI, et al. “Tamoxifen Therapy for Primary Breast Cancer and Risk of Contralateral Breast Cancer.” JNCI: Journal of the National Cancer Institute, vol. 93, no. 13, July 2001, pp. 1008–13. EBSCOhost, https://doi.org/10.1093/jnci/93.13.1008.

APA

Li CI, Malone KE, Weiss NS, Daling JR, Li, C. I., Malone, K. E., Weiss, N. S., & Daling, J. R. (2001). Tamoxifen therapy for primary breast cancer and risk of contralateral breast cancer. JNCI: Journal of the National Cancer Institute, 93(13), 1008–1013. https://doi.org/10.1093/jnci/93.13.1008

Chicago

Li CI, Malone KE, Weiss NS, Daling JR, C I Li, K E Malone, N S Weiss, and J R Daling. 2001. “Tamoxifen Therapy for Primary Breast Cancer and Risk of Contralateral Breast Cancer.” JNCI: Journal of the National Cancer Institute 93 (13): 1008–13. doi:10.1093/jnci/93.13.1008.